Author Details

Artemeva, Antonina V.

Issue	Section	Title	File
Vol 97, No 4 (2021)	ORIGINAL STUDIES	Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial	(Rus)
Vol 98, No 2 (2022)	ORIGINAL STUDIES	Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial	(Rus)